With more proven potential than ever before, I don't foresee that being a problem. If there is no partnership or BO imminent, we may only need to sell a small chunk to reach the end of Brazil trial.

We've sold quite a few shares over the years, millions at lower pps and millions at a higher pps. Cytodyn ain't going bankrupt anytime soon.

I suspect we're on the brink of a partner or BO and whomever the other party is wanted the pps low throughout negotiations.